Cacti Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Cacti Asset Management's LKFT Position: Q3 2026 in Review
Cacti Asset Management opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 1,000 shares worth $29.5K. The stake represents ﹤0.01% of the portfolio and ranks #77 among its holdings. This is a return to the name: Cacti Asset Management previously reported a position in LKFT as recently as Q1 2026.
Cacti Asset Management first reported a position in LKFT in Q3 2020 and has held it in 24 quarters since. The position peaked at $355K in Q3 2020. 13 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- Cacti Asset Management held 1,000 shares of Lakefront Biotherapeutics American Depositary Shares worth $29.5K as of Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares was a new Cacti Asset Management position in Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Cacti Asset Management's portfolio in Q3 2026, its #77 holding.
- Cacti Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2020 and has held it in 24 quarters since.
- Cacti Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $355K in Q3 2020.
- 13 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on Cacti Asset Management's 13F filing for Q3 2026, filed 1 Oct 2026.